It normally causes mucosal inflammation, intestinal ulcers, and histological damage and triggers colonic expression of the proinflammatory cytokines TNF-α, IL-1β, and IL-6 in 14 days after the TNBS administration [18]. The gene discussed is TNF; the disease is intestinal disorder.